News
10-27-2011, 03:10 PM
Ever since FDA Advisers rejected Avastin's (bevacizumab's) indication for metastatic breast cancer in 2010, a controversy among health care professionals has grown...
More... (http://www.medicalnewstoday.com/articles/236688.php)
More... (http://www.medicalnewstoday.com/articles/236688.php)